WAT logo

Waters (WAT)

Profile

Full Name

Waters Corporation

Ticker Symbol

WAT

Exchange

NYSE

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

November 17, 1995

Indexes

S&P 500

Website

http://www.waters.com

Employees

7600

Key Details

Price

$323.44(-3.09%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.96B(+0.07% YoY)

Annual EPS

$10.71(-1.20% YoY)

PE ratio

30.20

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$323.44
WAT price is $323.44

30-Day Relative Volume

0.79
WAT 30-day relative volume is 0.79

Price Performance

Price Today change

-3.09%
WAT price is down -3.09% today

Price YTD change

-12.81%
WAT price is down -12.81% since January 1st

Price 1-year change

+1.2%
WAT price is up +1.2% year-on-year

Price 3-year change

+9.5%
WAT price is up +9.5% over the past 3 years

Price Range

Price All-time high

$428.22
WAT price is currently -24.47% below its historical high of $428.22

Price 3-year low

$231.90
WAT price is currently +39.47% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$19.22B
WAT market capitalization is $19.22 billion

Market cap 3-year change

+7.75%
WAT market capitalization is up +7.75% over the past 3 years

Market cap All-time high

$26.06B
WAT market capitalization is currently -26.27% below its historical high of $26.06 billion

Market cap sector rank

95.64%
WAT market capitalization is higher than 95.64% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.17%
WAT shares outstanding is up +0.17% year-on-year

Shares Outstanding 3-Year Change

-1.59%
WAT shares outstanding is down -1.59% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.92
WAT beta is 0.92

200-day SMA

$357.11
WAT price is currently -9.43% below its 200-day simple moving average

50-day SMA

$370.07
WAT price is currently -12.60% below its 50-day simple moving average

RSI

40.13
WAT 14-day relative strength index is 40.13

Volume

0.79
WAT 30-day relative volume is 0.79

ATR

$18.04
WAT average true range is $18.04

10-day Historical Volatility

82.47%
WAT 10-day historical volatility is 82.47%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.96B
WAT annual revenue is $2.96 billion

Revenue Analysts estimate

$3.08B
WAT annual revenue is currently -3.85% lower than the consensus analysts' forecast

Revenue 1-year change

+0.07%
WAT annual revenue is up +0.07% year-on-year

Revenue Sector rank

88.35%
WAT annual revenue is higher than 88.35% of companies in Healthcare sector

EPS

EPS

$10.71
WAT annual earnings per share is $10.71

EPS Analysts estimate

$12.86
WAT annual earnings per share is currently -16.70% lower than the consensus analysts' forecast

EPS 1-year change

-1.2%
WAT annual earnings per share is down -1.2% year-on-year

EPS Sector rank

98.26%
WAT annual earnings per share is higher than 98.26% of companies in Healthcare sector

Profit

Gross profit

$1.76B
WAT annual gross profit is $1.76 billion

Gross margin

59.43%
WAT annual gross profit margin is 59.43%

Operating profit

$837.92M
WAT annual operating income is $837.92 million

Operating margin

28.32%
WAT annual operating profit margin is 28.32%

Net income

$637.83M
WAT annual net profit is $637.83 million

Net margin

21.56%
WAT annual net profit margin is 21.56%

Expenses

Total expenses

$2.12B
WAT annual total expenses is $2.12 billion

Operating expenses

$920.26M
WAT annual total operating expenses is $920.26 million

Cost of goods sold

$1.20B
WAT annual cost of goods sold is $1.20 billion

Selling, general & administrative expenses

$690.15M
WAT annual SGA is $690.15 million

Depreciation and amortization

$191.82M
WAT annual depreciation & amortization is $191.82 million

Interest expense

$89.68M
WAT annual interest expense is $89.68 million

Income tax

$117.03M
WAT annual income tax is $117.03 million

EBIT & EBITDA

EBIT

$827.13M
WAT annual earnings before interest & taxes is $827.13 million

EBITDA

$1.02B
WAT annual EBITDA is $1.02 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$4.55B
WAT annual total assets is $4.55 billion

Non current assets

$3.02B
WAT annual long term assets is $3.02 billion

Current assets

$1.54B
WAT annual total current assets is $1.54 billion

Cash and cash equivalents

$324.42M
WAT annual cash & cash equivalents is $324.42 million

Accounts receivable

$733.37M
WAT annual accounts receivable is $733.37 million

Inventory

$477.26M
WAT annual inventory is $477.26 million

Liabilities

Total liabilities

$2.73B
WAT annual total liabilities is $2.73 billion

Long term liabilities

$2.73B
WAT annual total long term liabilities is $2.73 billion

Current liabilities

$789.76M
WAT annual total current liabilities is $789.76 million

Accounts payable

$99.93M
WAT annual accounts payable is $99.93 million

Debt

Total debt

$1.70B
WAT annual total debt is $1.70 billion

Total debt 1-year change

-30.3%
WAT annual total debt is down -30.3% year-on-year

Long term debt

$1.68B
WAT annual long term debt is $1.68 billion

Short term debt

$25.54M
WAT annual short term debt is $25.54 million

Equity & Capital

Shareholders equity

$1.83B
WAT annual stockholders equity is $1.83 billion

Book value

$1.83B
WAT annual book value is $1.83 billion

Retained earnings

$9.79B
WAT annual retained earnings is $9.79 billion

Working capital

$879.35M
WAT annual working capital is $879.35 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$762.12M
WAT annual cash flow from operations is $762.12 million

Cash from operations 1-year change

+26.43%
WAT annual cash flow from operations is up +26.43% year-on-year

Cash from investing

-$144.02M
WAT annual cash flow from investing activities is -$144.02 million

Cash from investing 1-year change

+90.01%
WAT annual cash flow from investing activities is up +90.01% year-on-year

Cash from financing

-$696.67M
WAT annual cash flow from financing activities is -$696.67 million

Cash from financing 1-year change

-192.28%
WAT annual cash flow from financing activities is down -192.28% year-on-year

CAPEX

CAPEX

$142.48M
WAT annual capital expenditures is $142.48 million

CAPEX 1-year change

-11.3%
WAT annual capital expenditures is down -11.3% year-on-year

Free Cash Flow

Free cash flow

$619.64M
WAT annual free cash flow is $619.64 million

Free cash flow 1-year change

+40.13%
WAT annual free cash flow is up +40.13% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

59.43%
WAT annual gross profit margin is 59.43%

Operating margin

28.32%
WAT annual operating profit margin is 28.32%

Net margin

21.56%
WAT annual net profit margin is 21.56%

ROA & ROE

ROA

13.90%
WAT annual return on assets is 13.90%

ROE

42.82%
WAT annual return on equity is 42.82%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

30.20
WAT price to earnings ratio is 30.20

PE ratio Sector rank

60.78%
WAT price to earnings ratio is higher than 60.78% of companies in Healthcare sector

PB Ratio

PB ratio

10.51
WAT price to book ratio is 10.51

PB ratio Sector rank

93.17%
WAT price to book ratio is higher than 93.17% of companies in Healthcare sector

PS Ratio

PS ratio

6.50
WAT price to sales ratio is 6.50

PS ratio Sector rank

71.92%
WAT price to sales ratio is higher than 71.92% of companies in Healthcare sector

Enterprise value

Enterprise value

$20.59B
WAT enterprise value is $20.59 billion

Enterprise value Sector rank

94.88%
WAT enterprise value is higher than 94.88% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

19.96
WAT EV/EBITDA is 19.96

EV/EBITDA Sector rank

91.74%
WAT EV/EBITDA is higher than 91.74% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.11
WAT annual current ratio is 2.11

Quick ratio

1.34
WAT annual quick ratio is 1.34

Leverage

Debt to equity

0.89
WAT annual debt to equity ratio is 0.89

Interest coverage ratio

9.22
WAT annual interest coverage ratio is 9.22

Risk & Stability

Piotroski F-Score

5
WAT piotroski f-score is 5

Altman Z-Score

8.72
WAT altman z-score is 8.72

Analyst ratings

Recent major analysts updates

Apr 10, 25 Barclays
Equal-Weight
Mar 31, 25 Keybanc
Overweight
Mar 26, 25 Baird
Outperform
Mar 6, 25 JP Morgan
Neutral
Feb 13, 25 Wells Fargo
Overweight
Feb 13, 25 UBS
Neutral
Feb 13, 25 Scotiabank
Sector Outperform
Feb 13, 25 B of A Securities
Neutral
Feb 10, 25 Barclays
Equal-Weight
Dec 23, 24 Scotiabank
Sector Perform

Institutional Ownership

Similar stocks

ZBH logo
Zimmer Biomet Holdings (ZBH)
LH logo
Laboratory Corporation of America Holdings (LH)
MOH logo
Molina Healthcare (MOH)
DGX logo
Quest Diagnostics Incorporated (DGX)
SMMT logo
Summit Therapeutics (SMMT)
PODD logo
Insulet (PODD)
NTRA logo
Natera (NTRA)
BIIB logo
Biogen (BIIB)
STE logo
STERIS (STE)
  • What is the ticker symbol for Waters?
  • Does Waters pay dividends?
  • What sector is Waters in?
  • What industry is Waters in?
  • What country is Waters based in?
  • When did Waters go public?
  • Is Waters in the S&P 500?
  • Is Waters in the NASDAQ 100?
  • Is Waters in the Dow Jones?
  • When was Waters's last earnings report?
  • When does Waters report earnings?
  • Should I buy Waters stock now?

What is the ticker symbol for Waters?

The ticker symbol for Waters is NYSE:WAT

Does Waters pay dividends?

No, Waters does not pay dividends

What sector is Waters in?

Waters is in the Healthcare sector

What industry is Waters in?

Waters is in the Diagnostics & Research industry

What country is Waters based in?

Waters is headquartered in United States

When did Waters go public?

Waters's initial public offering (IPO) was on November 17, 1995

Is Waters in the S&P 500?

Yes, Waters is included in the S&P 500 index

Is Waters in the NASDAQ 100?

No, Waters is not included in the NASDAQ 100 index

Is Waters in the Dow Jones?

No, Waters is not included in the Dow Jones index

When was Waters's last earnings report?

Waters's most recent earnings report was on Feb 12, 2025

When does Waters report earnings?

The next expected earnings date for Waters is May 6, 2025

Should I buy Waters stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page